Pharmaceutical manufacturers of Levothyroxine sodium

Headquartered in Mumbai, India, Lupin is a global pharmaceutical leader with a footprint across the U.S., LATAM, APAC, EMEA and India, with products distributed in over 100 markets. With a diverse portfolio of over 1,200 products, Lupin remains committed to its mission of making quality healthcare accessible to the communities we serve. Our visionary Founder, Dr. Desh Bandhu Gupta, instilled in us the importance of offering quality, affordable and innovative medicines and being a responsible corporate citizen, making a positive difference to patients, communities and the environment.

AbbVie Contract Manufacturing boasts more than three decades of expertise in AbbVie's manufacturing sector. Operating as an integrated CMO, it harnesses extensive knowledge, cooperation, and state-of-the-art facilities, delivering comprehensive services to customers across various domains such as development, production, compliance, and marketing, while ensuring adherence to the highest international benchmarks. Additionally, AbbVie Contract Manufacturing aids clients in streamlining manufacturing, optimizing supply networks, expediting time-to-market, ensuring adherence to regulations, and providing unparalleled quality.

Rakshit Corporation, has a long-standing presence in the field of API production, operating for more than 20 years and possessing facilities that are sanctioned by USFDA, Japan-PMDA, Korean FDA, and multiple approved CEPs. Rakshit stands as the primary global producer of Sildenafil Citrate API and its intermediates, specializing in the production of Erectile Dysfunction APIs. The Rakshit conglomerate is equipped with three manufacturing units that comply with cGMP standards.

With more than six decades of experience as a leading supplier of materials to the pharmaceutical sector, we comprehend the requirements necessary to support our clients' achievements. Solvay possesses a diverse range of specialty polymers that empower pharmaceutical firms to create novel and improved applications, ultimately ensuring safer and more effective outcomes for patients worldwide

Established in Darmstadt, Germany in 1668 by Friedrich Jacob Merck, Merck KGaA stands as the oldest pharmaceutical and chemical corporation globally. It is renowned for its pioneering and high-quality advanced products in the fields of healthcare, life science, and performance materials. Internationally, the company is recognized as Merck, while operating as EMD Serono in the Biopharma sector, as MilliporeSigma in the Life Science sector, and as EMD Performance Materials in the materials sector in the United States and Canada.

FAREVA stands as a prominent global pharmaceutical CDMO with leading expertise in the development and production of a wide variety of Drug Products and Active Pharmaceutical Ingredients (APIs). The company has a workforce of 13,000 individuals spread across 41 manufacturing facilities situated in 13 countries across EMEA and the Americas. Among these facilities, 18 are exclusively dedicated to pharmaceutical operations. FAREVA’s API division carries out its activities in 3 European locations situated in France and Germany.

In just over a decade, Laurus has positioned itself as one of the largest and most innovative API producers globally. Expanding upon its established expertise in chemistry, Laurus has recently adopted full vertical integration, including a strong finished dosage capacity, dedicated capacity for backward integration, and also Synthesis R&D operations in India and the USA.

Established in 1978 as a specialized facility for Small Volume Parenterals (SVPs), Gland Pharma has evolved into a forward-thinking and quality-focused organization catering to the pharmaceutical requirements of diverse global markets. The company possesses state-of-the-art facilities for injectables established in partnership with Vetter Group, Germany, providing Gland Pharma a technological advantage in injectables, particularly in Pre Filled Syringes.

Greetings, we are Sandoz B2B. As a division of Sandoz, we are completely dedicated to ensuring availability of cost-effective medication for everyone. We distribute high-quality medication globally through close collaboration with pharmaceutical partners. Whether it involves active pharmaceutical ingredients, finished dosage products, or comprehensive end-to-end CDMO solutions, we are here for you.

Aurore Life Sciences is a specialized manufacturer of active pharmaceutical ingredients (API) with a varied range of capabilities to enhance efficiency for generic pharmaceutical companies worldwide. Established in 2017 by a team with extensive expertise throughout the pharmaceutical supply chain, the company is dedicated to becoming the most favored partner for pharmaceuticals. At Aurore, we strive to innovate in the production and delivery of dependable high-quality products, earning the trust of both customers and regulatory bodies. Our focus on rapidly expanding capabilities has driven us to acquire, integrate, and extend our presence across multiple regions.

Azico Biophore India Pvt. Ltd. operates a facility for manufacturing active pharmaceutical ingredients (APIs) which has undergone successful inspections by the US FDA on three occasions, with the most recent audit conducted in February 2019. The company holds 22 active Drug Master Files (DMFs). They offer a Customized Business Model, providing supplies from conceptualization to commercialization, as well as contract manufacturing of APIs, Key Starting Materials (KSMs), and Intermediates.

Yangtze River Pharmaceutical Group, also known as YRPG, is a major pharmaceutical conglomerate based in China that was established in 1971. As of July 2019, YRPG spans over 3 million square meters and operates 14 manufacturing subsidiaries situated in various areas including Beijing, Shanghai, Nanjing, and Guangzhou. It has also established research and development as well as production facilities for innovative chemical medicine and traditional patented products.

Shree Venkatesh International Limited has established itself as a rapidly growing and distinguished Indian company dedicated to the production, promotion, and export of Hormonal products. Our state-of-the-art facility is equipped with advanced technologies specifically designed for a wide range of Gynecological, IVFs, and Contraceptives Hormonal products. At Shree Venkatesh International Limited, we tirelessly strive to develop highly efficient and safe hormonal products and make them accessible at the most competitive prices globally. Our portfolio includes Injectables, lyophilized powder, and hormonal Oral tablets, contributing to the enhancement of reproductive health on a global scale. Our WHO-GMP (India) plant has been inspected and approved by regulatory bodies in Yemen (SBDMA), Kenya (PPB), Nigeria (NAFDAC), Cambodia, and the Philippines. We have plans to extend our product reach to countries in the CIS, African, Southern Asian, Southern American, PIC/s, and MENA regions. For further information, please visit www.shreevenkatesh.com. Shree Venkatesh International Limited is an ISO9001:2008 Certified company registered under the Registrar of Companies Act, specializing in the export of Generic Medicines, Pharmaceutical formulations, and Bulk drugs from India. The company is based in Gujarat, which is renowned as the Manufacturing Hub for Pharmaceutical formulations in India.

Innova Pharmactive Pvt. Ltd., formerly known as Innova Laboratories, is a producer and promoter with a diverse array of products spanning various therapeutic categories. Established in 1994 as a solitary product maker, Innova experienced significant growth under the guidance of our late Founder, Rajesh Khandelwal, and Rakesh Khandelwal. Drawing inspiration from them, Innova has established itself as a highly favored supplier of Active Pharmaceutical Ingredients (APIs) and intermediates for top global pharmaceutical firms.